Fundamental dimension Equity attribute | DGTHFLeader $0.695▼-0.00% Cap $7.53MP/E -7.5x QuantScore42/100 | CEXEPeer $0.00010.00% Cap $6.51KP/E -0.0x QuantScore23/100 | DTTVYPeer $0.00010.00% Cap $184.1KP/E -0.4x QuantScore32/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
59/100 |
40/100 |
68/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 33/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 27/100 | 20/100 | 25/100 |
Growth Revenue / earnings growth & margins | 50/100 | 0/100 | 1/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -7.5x | -0.0x | -0.4x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -30.2x | -4.4x | -1.2x |
Price / Sales | — | — | 0.3x |
Price / Free Cash Flow | -76.5x | -0.0x | -13.8x |
PEG ratio | 0.01 | 0.00 | 0.01 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 1 / 9 | 2 / 9 |
Altman Z-Score | -172.92 (Distress) | -378.73 (Distress) | — |
Total debt / equity | -0.14 | -0.60 | 0.00 |
Quick ratio | 0.2x | 0.0x | — |
Interest coverage | -418.3x | -3.4x | -2.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | -22.0% |
Net income growth YoY | +115.4% | -81.8% | -74.2% |
Gross margin (TTM) | 0.0% | 0.0% | -17.9% |
Operating margin (FY) | — | — | -36.2% |
FCF margin (FY) | — | — | -1.3% |
5. Trailing price performancePrice change over period |
1M return | 0.0% | +0.0% | +0.0% |
3M return | 0.0% | +150.0% | +0.0% |
6M return | -53.7% | -97.5% | +0.0% |
Year to date | -53.7% | -97.5% | 0.0% |
1Y return | +2474.1% | -97.5% | +0.0% |
3Y return | +33.5% | -97.5% | -99.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.0324 -104.7% premium | $-0.2458 -245899.7% premium | $-0.0049 -5009.3% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |